Effective Solutions Founded on Deep Industry Expertise
We have 40 years of experience in Healthcare, Life Sciences, and Health Economics and Outcomes Research. Our solutions focus on integrating disparate data sets in creative ways to identify the patients and populations with the highest unmet needs and to discover the optimal ways to address these needs.
Changing Outcomes With Our Real World Data Applications
Learn how our partners and clients are utilizing Atomo’s rich set of data mining and machine learning applications to rethink their processes, change outcomes and engineer a brighter future.
Measuring the Impact of Restrictive Prior Authorization Policies Utilizing Real World Data
Our team quantified the negative cardiac outcomes for patients who had a rejected or abandoned PCSK9i prescriptions.
Finding Undiagnosed Familial Hypercholesterolemia (FH) patients within Network
The Atomo team worked with Stanford and the Family Heart Foundation to find undiagnosed FH patients in Stanford’s health network.
A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases
Atomo mapped current U.S. health care utilization in patients with IBDs using a national insurance claims database.
Therapeutic Areas of Expertise
We work with patients, providers, hospitals, advocacy groups and life sciences organizations to impact the outcomes and lives for millions of patients.
- Acute angina
- Acne
- Acute Myeloid Leukemia
- Attention deficit hyperactivity disorder
- Allergic Rhinitis
- Alpha-1 deficiency
- Alzheimer’s
- Anesthesia
- Anemia
- Ankylosing Spondylitis
- Anti-platelet
- Asthma
- Antiviral
- Atrial fibrillation
- Bipolar disorder
- Blood cancers
- Benign prostatic hyperplasia
- Breast cancer
- Cervical dystonia
- Chronic kidney disease
- Chronic granulomatous disease (CGD)
- Chronic obstructive pulmonary disease
- Chronic Renal Failure
- Crohn’s Disease
- Cushing’s Disease
- Cytomegalovirus disease
- Depression
- Dermatology
- Device for pain
- Diabetes
- Dry Eye
- Dyslipidemia (includes High Cholesterol)
- Dupuytren’s contracture
- Emphysema
- Endometriosis
- Epilepsy
- Familial Hypercholesterolaemia
- Fibroids
- Fibromyalgia
- Glaucoma
- Glioblastoma
- Gout
- Herpes
- Hormone replacement therapy
- Hypertension
- Hypertriglyceridemia
- Hypothyroid
- Hyperthyroid
- Immunoglobulin
- Insomnia
- Leukemia
- Lipids
- Lupus
- Menorrhagia
- Multiple Myeloma
- Multiple sclerosis
- Myelofibrosis
- Obesity
- Ophthalmology Allergy
- Ophthalmology Anti-Infective
- Ophthalmology Antiviral
- Osteoarthritis
- Osteoporosis
- Ovarian cancer
- Over active bladder
- Pain-acute
- Pain-chronic
- Parkinson’s Disease
- Post-Cataract Surgery
- Post-Ocular Surgery
- Prostate cancer
- Psoriasis
- Peripheral T-cell lymphoma
- Purified protein
derivative - Rare neurological condition confidential to client
- Retinal Conditions
- Rheumatoid
arthritis - Rosacea
- Schizophrenia
- Sleep Disorders
- Spinal fracture
- Stroke
- Thyroid cancer
- Transplant
(Heart, Kidney,
Liver, Lung) - Woman’s health condition confidential to client
Experts in Their Own Right, Bring Team Expertise
Atomo is Greek for individual. We are driven to discover individuals and populations with the highest unmet need in a disease state or condition so that the challenges they face can be resolved. With over 30 years of experience in Healthcare, Life Sciences, and Health Economics and Outcomes Research we have both the skills and the passion to get the job done.
Kelly D. Myers
CEO
Kelly D Myers is a Healthcare IT entrepreneur with over 35 years’ experience. He has held senior level positions in Fortune 100 pharmaceutical companies and has founded and led successful healthcare analytics startups. Kelly is the Founder and CEO of Atomo, Inc. Atomo utilizes machine learning technologies and leverages human insight to empower healthcare stakeholders to solve complex healthcare challenges. Kelly also serves as the Chief Technology Officer to the Familial Hypercholesterolemia (FH) Foundation and leads the FIND FH initiative. His responsibilities include leading the development of the data-mining platform. FIND FH will deliver the largest integrated database designed to identify possible individuals with FH.
Kelly also served as an executive committee member of the Crohn’s and Colitis Foundation of America Partners, Patient Powered Research Network. His responsibilities included leading the efforts to develop the first known analytic solution that integrates Quantified Self and EHR data to provide real time feedback to allow individuals with Inflammatory Bowel Disease (IBD) to better understand and manage their own disease. In collaboration with the UCLA Center for Inflammatory Bowel Diseases, Kelly was a co-author of a work that demonstrated the value of mining national claims databases to identify opportunities to improve specialty care in IBD. The study was presented at Digestive Disease Week in 2013.
As Cofounder and CEO, Kelly led Qforma in its mission to raise the bar in analytics by providing healthcare organizations with advanced tools that identify useful patterns in complex data and deliver actionable information. Qforma was a “boot strapped” company that grew from Kelly as the single employee to 50 employees between 2000 and 2013 with minimal investment. Qforma had a successful exit to a private equity firm in 2013.
William B. Howard, PhD
Operations and Data Science
In 1997, as a Hertz Foundation Fellow, Dr. Howard earned his Ph.D. in Physics from the Massachusetts Institute of Technology. While at M.I.T., he measured the neutron yield of the reaction 9Be(p,n) which he used to design radiation delivery systems for an experimental cancer therapy, Boron Neutron Capture Therapy.
In 1997, Dr. Howard joined KLA-Tencor, a leading supplier of capital equipment for the semiconductor industry. At KLA-Tencor he held positions as Field Engineer, Engineering Manager and Research Scientist. Dr. Howard modeled, at the nanometer scale, the electron-beam, optical and chemical processes used to make integrated circuits. Dr. Howard has invented, developed and marketed computational lithography products for the semiconductor industry.
Dr. Howard joined Qforma, a leader in healthcare analytics, in 2009. He led the Client Services and New Product Development groups. He managed the development of a web-based suite of applications optimized for mobile devices. In 2013, Dr. Howard became the Chief Operating Officer of Qforma and was responsible for operations in the US and Europe.
In 2014, Dr. Howard joined JP3 Measurement, a start-up company using near infrared absorption spectroscopy to analyze oil and natural gas. As VP Engineering, Dr. Howard managed the chemical analysis team, designed JP3’s web-based business intelligence system, and launched Apple and Android mobile apps.
Since 2017, Dr. Howard has led operations and data science at Atomo, Inc. He manages the data analysis team, oversees client engagements, and contributes to analytical and innovation projects.
Po-Ya Hsu, PhD
Senior Data Scientist
Po-Ya Hsu is a senior data scientist at Atomo where she leads the machine learning modeling and advanced analytics efforts. She is a published researcher in peer-reviewed conferences and journals from multiple fields, including artificial intelligence, wearable devices, and medicine.
Dr. Hsu earned a B.S. from National Taiwan University in Electrical Engineering in 2016 and a Ph.D. from UCSD in Computer Science in 2021. At UCSD, she focused on inventing predictive models for healthcare, including multi-label arrhythmia diagnosis, mild traumatic brain injury identification, and acute kidney injury prediction. She also worked on prototyping wearable devices for biomedical applications. During her time in UCSD, Po-Ya was awarded the Unicorn Award for her wearable device and won the Editor’s Choice of 2021 ACS Nano Applied Materials in her interdisciplinary collaboration.
In 2022, Po-Ya worked in Microsoft as Applied Scientist. She has delivered several advertisement recommendation products. While at Microsoft, Po-Ya specialized in leveraging large language models and graph neural network models to optimize product implementation.
Reimagine Better Solutions
Atomo can help you leverage technology and big data to solve your most difficult healthcare challenges